WallStSmart

HealthEquity Inc (HQY)vsPrivia Health Group Inc (PRVA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Privia Health Group Inc generates 62% more annual revenue ($2.12B vs $1.31B). PRVA leads profitability with a 108.0% profit margin vs 16.4%. HQY trades at a lower P/E of 33.4x. HQY earns a higher WallStSmart Score of 68/100 (B-).

HQY

Strong Buy

68

out of 100

Grade: B-

Growth: 8.0Profit: 7.0Value: 10.0Quality: 6.5
Piotroski: 4/9

PRVA

Hold

48

out of 100

Grade: D+

Growth: 8.7Profit: 5.5Value: 3.0Quality: 8.0
Piotroski: 4/9Altman Z: 3.09
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HQYUndervalued (+33.2%)

Margin of Safety

+33.2%

Fair Value

$115.13

Current Price

$82.47

$32.66 discount

UndervaluedFair: $115.13Overvalued
PRVASignificantly Overvalued (-156.5%)

Margin of Safety

-156.5%

Fair Value

$8.42

Current Price

$20.54

$12.12 premium

UndervaluedFair: $8.42Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HQY3 strengths · Avg: 8.7/10
EPS GrowthGrowth
92.4%10/10

Earnings expanding 92.4% YoY

PEG RatioValuation
0.898/10

Growing faster than its price suggests

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

PRVA5 strengths · Avg: 9.6/10
Profit MarginProfitability
108.0%10/10

Keeps 108 of every $100 in revenue as profit

EPS GrowthGrowth
132.8%10/10

Earnings expanding 132.8% YoY

Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.0910/10

Safe zone — low bankruptcy risk

Revenue GrowthGrowth
17.4%8/10

17.4% revenue growth

Areas to Watch

HQY1 concerns · Avg: 4.0/10
P/E RatioValuation
33.4x4/10

Premium valuation, high expectations priced in

PRVA3 concerns · Avg: 2.7/10
Return on EquityProfitability
4.0%3/10

ROE of 4.0% — below average capital efficiency

Operating MarginProfitability
2.1%3/10

Operating margin of 2.1%

P/E RatioValuation
116.8x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : HQY

The strongest argument for HQY centers on EPS Growth, PEG Ratio, Operating Margin. Profitability is solid with margins at 16.4% and operating margin at 21.6%. PEG of 0.89 suggests the stock is reasonably priced for its growth.

Bull Case : PRVA

The strongest argument for PRVA centers on Profit Margin, EPS Growth, Debt/Equity. Profitability is solid with margins at 108.0% and operating margin at 2.1%. Revenue growth of 17.4% demonstrates continued momentum.

Bear Case : HQY

The primary concerns for HQY are P/E Ratio.

Bear Case : PRVA

The primary concerns for PRVA are Return on Equity, Operating Margin, P/E Ratio. A P/E of 116.8x leaves little room for execution misses.

Key Dynamics to Monitor

HQY profiles as a mature stock while PRVA is a growth play — different risk/reward profiles.

PRVA carries more volatility with a beta of 0.82 — expect wider price swings.

PRVA is growing revenue faster at 17.4% — sustainability is the question.

PRVA generates stronger free cash flow (126M), providing more financial flexibility.

Bottom Line

HQY scores higher overall (68/100 vs 48/100), backed by strong 16.4% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HealthEquity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.

Privia Health Group Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Privia Health Group, Inc. is a population health technology and medical practice management company in the United States.

Visit Website →

Want to dig deeper into these stocks?